학술논문

A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma
Document Type
Article
Source
In: Nature Communications. (Nature Communications, December 2022, 13(1))
Subject
Language
English
ISSN
20411723